Cargando…
Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
1994
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119550/ http://dx.doi.org/10.1016/0165-5728(94)90354-9 |
| _version_ | 1783514788807049216 |
|---|---|
| author | Henneberg, A.E. Pfau, J. Hartmann, P. Bittmann, H. Link, D. Wollinsky, K.H. |
| author_facet | Henneberg, A.E. Pfau, J. Hartmann, P. Bittmann, H. Link, D. Wollinsky, K.H. |
| author_sort | Henneberg, A.E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7119550 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1994 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71195502020-04-08 Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy? Henneberg, A.E. Pfau, J. Hartmann, P. Bittmann, H. Link, D. Wollinsky, K.H. J Neuroimmunol Abstract Published by Elsevier B.V. 1994-10 2002-12-10 /pmc/articles/PMC7119550/ http://dx.doi.org/10.1016/0165-5728(94)90354-9 Text en Copyright © 1994 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Abstract Henneberg, A.E. Pfau, J. Hartmann, P. Bittmann, H. Link, D. Wollinsky, K.H. Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy? |
| title | Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy? |
| title_full | Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy? |
| title_fullStr | Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy? |
| title_full_unstemmed | Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy? |
| title_short | Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy? |
| title_sort | brain antibodies in ms-patients — an activity parameter for immunosuppressive therapy? |
| topic | Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119550/ http://dx.doi.org/10.1016/0165-5728(94)90354-9 |
| work_keys_str_mv | AT hennebergae brainantibodiesinmspatientsanactivityparameterforimmunosuppressivetherapy AT pfauj brainantibodiesinmspatientsanactivityparameterforimmunosuppressivetherapy AT hartmannp brainantibodiesinmspatientsanactivityparameterforimmunosuppressivetherapy AT bittmannh brainantibodiesinmspatientsanactivityparameterforimmunosuppressivetherapy AT linkd brainantibodiesinmspatientsanactivityparameterforimmunosuppressivetherapy AT wollinskykh brainantibodiesinmspatientsanactivityparameterforimmunosuppressivetherapy |